DECREASED ARGININE-INDUCED HGH RESPONSE DURING L-DOPA THERAPY IN PARKINSONIAN PATIENTS

被引：4
作者：
JOHNSON, SE
NORMAN, N
SJAASTAD, O
机构：
[1] RIKS HOSP OSLO,DEPT NEUROL,OSLO,NORWAY
[2] AKER HOSP,HORMONE LAB,OSLO,NORWAY
来源：
ACTA ENDOCRINOLOGICA | 1974年 / 77卷 / 04期
关键词：
D O I：
10.1530/acta.0.0770686
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：686 / 690
页数：5
相关论文
共 50 条
[31]   PSYCHOMOTOR EFFECTS OF L-DOPA COMBINED WITH A DECARBOXYLASE INHIBITOR ON PARKINSONIAN PATIENTS [J].
KLAIBER, B ;
SIEGFRIE.J ;
ZIEGLER, WH ;
PERRET, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1971, 3 (03) :172-&
[32]   NIACIN DEPLETION IN PARKINSONIAN PATIENTS TREATED WITH L-DOPA, BENSERAZIDE AND CARBIDOPA [J].
BENDER, DA ;
EARL, CJ ;
LEES, AJ .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1979, 56 (01) :89-93
[33]   OCCURRENCE OF A NEW CLASS OF TETRAHYDROISOQUINOLINES IN L-DOPA TREATED PARKINSONIAN PATIENTS [J].
COSCIA, CJ ;
BURKE, W ;
JAMROZ, G ;
KOSLOFF, A ;
MCFARLANE, J ;
MITCHELL, J ;
WILSON, ML .
FEDERATION PROCEEDINGS, 1977, 36 (03) :804-804
[34]   MECHANISM OF NULLIFICATION OF CNS EFFECTS OF L-DOPA BY PYRIDOXINE IN PARKINSONIAN PATIENTS [J].
PFEIFFER, R ;
EBADI, M .
JOURNAL OF NEUROCHEMISTRY, 1972, 19 (09) :2175-+
[35]   L-DOPA THERAPY OF PARKINSONS DISEASE - PLASMA L-DOPA CONCENTRATION, THERAPEUTIC RESPONSE, AND SIDE EFFECTS [J].
MUENTER, MD ;
TYCE, GM .
MAYO CLINIC PROCEEDINGS, 1971, 46 (04) :231-&
[36]   Acoustic analysis of Parkinsonian speech I: Speech characteristics and L-Dopa therapy [J].
Goberman, AM ;
Coelho, C .
NEUROREHABILITATION, 2002, 17 (03) :237-246
[37]   Automated gait analysis in bilateral Parkinsonian rats and the role of L-DOPA therapy [J].
Westin, J. E. ;
Janssen, M. L. F. ;
Sager, T. N. ;
Temel, Y. .
BEHAVIOURAL BRAIN RESEARCH, 2012, 226 (02) :519-528
[38]   BEHAVIOR OF SOMATOTROPIC HORMONE (HGH) AFTER L-ARGININE AND L-DOPA STIMULATION IN PATIENT AFTER SURGERY FOR CRANIOPHARYNGIOMA [J].
ESPOSITO, V ;
BELLASTELLA, A ;
DALESSAN.B ;
IACONO, G ;
MONTANO, A .
BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 1973, 49 (10) :592-598
[39]   FUTURE OF PARKINSONIAN PATIENTS - LONG-TERM RESULTS OF L-DOPA THERAPY FOR PARKINSONS-DISEASE [J].
BONDUELLE, M .
SEMAINE DES HOPITAUX THERAPEUTIQUE, 1977, 53 (7-8) :406-406
[40]   PROBLEMATICS AND THERAPY OF APPEARANCE OF L-DOPA INDUCED DYSKINESIA [J].
VOLLER, GW ;
DEZE, J ;
GUNDLACH, U ;
MUSCHARD, F .
NERVENARZT, 1972, 43 (11) :584-&
12345